ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
0.00%
US Tech 100
18,438.80
1.15%
S&P 500
5,307.01
0.00%
US Dollar vs CAD
1.36688
-0.17%
Bitcoin
69,836.98
1.06%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Invivyd Inc (IVVD)

  7. Invivyd Inc (IVVD) News

IVVD

Invivyd (IVVD)

Invivyd Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IVVD
DateTimeSourceHeadlineSymbolCompany
05/22/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
05/22/20246:00AMGlobeNewswire Inc.Invivyd Elects Two New Independent Members to its Board of DirectorsNASDAQ:IVVDInvivyd Inc
05/16/20243:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IVVDInvivyd Inc
05/13/20243:01PMGlobeNewswire Inc.Invivyd to Participate at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:IVVDInvivyd Inc
05/09/20243:32PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IVVDInvivyd Inc
05/09/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IVVDInvivyd Inc
05/09/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
05/09/20243:01PMGlobeNewswire Inc.Invivyd Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
05/07/20246:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
05/07/20246:30AMGlobeNewswire Inc.Invivyd to Pursue Rapid Immunobridging Pathway to Potential EUA for Treatment of COVID-19 in Moderately to Severely Immunocompromised People, Based on U.S. FDA FeedbackNASDAQ:IVVDInvivyd Inc
05/02/20244:13PMGlobeNewswire Inc.Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business HighlightsNASDAQ:IVVDInvivyd Inc
04/30/20246:30AMGlobeNewswire Inc.Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash PositionNASDAQ:IVVDInvivyd Inc
04/15/20246:30AMGlobeNewswire Inc.Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™NASDAQ:IVVDInvivyd Inc
04/12/20246:30AMGlobeNewswire Inc.Invivyd Announces CEO TransitionNASDAQ:IVVDInvivyd Inc
04/04/20243:01PMGlobeNewswire Inc.Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 MillionNASDAQ:IVVDInvivyd Inc
03/28/20246:00AMGlobeNewswire Inc.Invivyd Reports Full Year 2023 Financial Results and Recent Business HighlightsNASDAQ:IVVDInvivyd Inc
03/22/20242:28PMGlobeNewswire Inc.Invivyd Announces Interim Exploratory Data on VYD222 from Ongoing CANOPY Clinical TrialNASDAQ:IVVDInvivyd Inc
03/22/20242:04PMGlobeNewswire Inc.Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposure Prophylaxis (PrEP) of COVID-19NASDAQ:IVVDInvivyd Inc
02/12/20243:01PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:IVVDInvivyd Inc
02/09/20243:47PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IVVDInvivyd Inc
02/09/20243:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
02/05/20243:02PMGlobeNewswire Inc.Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IVVDInvivyd Inc
01/26/20243:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
01/26/20243:31PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
01/08/20246:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
01/03/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
01/03/20246:00AMGlobeNewswire Inc.Invivyd Submits Request for Emergency Use Authorization (EUA) to U.S. FDA for VYD222 for the Pre-exposure Prevention of COVID-19 in Immunocompromised Adults and AdolescentsNASDAQ:IVVDInvivyd Inc
12/22/20233:53PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IVVDInvivyd Inc
12/22/20233:51PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IVVDInvivyd Inc
12/20/20233:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IVVDInvivyd Inc
 Showing the most relevant articles for your search:NASDAQ:IVVD

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
UBQU
Ubiquitech Software (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
DPLS
DarkPulse (PK)
AMEX
SPY
SPDR S&P 500
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
FCEL
FuelCell Energy
USOTC
BLEG
Branded Legacy (PK)
USOTC
SONGD
Music Licensing (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
TDRK
TideRock Companies (PK)
USOTC
AXXA
Exxe (PK)
USOTC
GNCP
GNCC Capital (CE)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved